Zobrazeno 1 - 10
of 21
pro vyhledávání: '"International Journal of High Throughput Screening"'
Autor:
Stephen J. Kron, Edwardine Labay, Benjamin K Quarshie, Ralph R. Weichselbaum, Daniel W. Golden, Elena V. Efimova
Publikováno v:
International journal of high throughput screening
Edwardine Labay, Elena V Efimova, Benjamin K Quarshie, Daniel W Golden, Ralph R Weichselbaum, Stephen J KronLudwig Center for Metastasis Research, University of Chicago, Chicago, IL, USAAbstract: Much like replicative senescence, the irreversible cel
Publikováno v:
International Journal of High Throughput Screening.
Roopasri Ranganatha, Sridhara Chakravarthy, Sunilkumar Sukumaran Anthem Biosciences Pvt Ltd, Bangalore, India Abstract: New molecules targeted at enhancing quality of life undergo various tests to evaluate their efficacy and biosafety before approval
Autor:
Lodovico di Gioia, Sabine Gaudichon, David Macherel, Marie-Hélène Avelange-Macherel, Aurélia Rolland, Volker Baecker, Abdelilah Benamar, Antoine Pierart
Publikováno v:
International Journal of High Throughput Screening
International Journal of High Throughput Screening, Dove Medical Press, 2013, pp.1. ⟨10.2147/IJHTS.S40565⟩
International Journal of High Throughput Screening, Dove Medical Press, 2013, pp.1. ⟨10.2147/IJHTS.S40565⟩
Abdelilah Benamar,1 Antoine Pierart,1 Volker Baecker,2 Marie-Hélène Avelange-Macherel,3 Aurélia Rolland,1 Sabine Gaudichon,4 Lodovico di Gioia,4 David Macherel11Université d’Angers, Lunam Université, Angers, 2MRI-Montpellier RIO Imaging, Montp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b85f757f6ca4a7fef689addadcc674b
https://hal.univ-angers.fr/hal-03194924
https://hal.univ-angers.fr/hal-03194924
Autor:
Steve Finkbeiner
Publikováno v:
International Journal of High Throughput Screening.
Finkbeiner S, Skibinski G. Drug discovery in Parkinson's disease: update and developments in the use of cellular models. International Journal of High Throughput Screening.2011:2 15-25.The authors' affiliations should be as displayed below.Gaia Skibi
Autor:
Finkbeiner, Steve, Skibinski
Publikováno v:
International Journal of High Throughput Screening.
Gaia Skibinski, Steven FinkbeinerGladstone Institute of Neurological Disease, San Francisco, CA, USAAbstract: Parkinson's disease is the second most common neurodegenerative disorder and is characterized by the degeneration of dopaminergic neurons wi
Autor:
Kira Gianni, Melissa A. Liriano, Eric A. Toth, Thomas H. Charpentier, David J. Weber, Andrew Coop, Kristen M. Varney, Alex D. MacKerell, Paul T. Wilder, Edwin Pozharski
Publikováno v:
International journal of high throughput screening. 2010(1)
Paul T Wilder1,2, Thomas H Charpentier1, Melissa A Liriano1, Kira Gianni1, Kristen M Varney1, Edwin Pozharski3, Andrew Coop3, Eric A Toth1, Alex D MacKerell3, David J Weber1,21Department of Biochemistry and Molecular Biology, The University of Maryla
Autor:
Rao, Veena
Publikováno v:
International Journal of High Throughput Screening.
Gayathri Gopalan1, Veena S Rao1, Vijay V Kakkar21Tata Proteomics and Coagulation Unit, Thrombosis Research Institute, Bangalore, India; 2Thrombosis Research Institute, London, United KingdomAbstract: A major challenge in clinical proteomics is the id
Autor:
Truskey, George A.
Publikováno v:
International Journal of High Throughput Screening.
George A TruskeyDepartment of Biomedical Engineering, Duke University, Durham, NC, USAAbstract: Drug development for many diseases would be aided greatly by accurate in vitro model systems that replicate key elements of in vivo physiology. The recent
Publikováno v:
International Journal of High Throughput Screening.
Zsigmond Benko1, Robert T Elder2, Dong Liang1, Richard Y Zhao11Department of Pathology, Department of Microbiology-Immunology, Institute of Human Virology, University of Maryland Medical School, Baltimore, MD, USA; 2Children’s Memorial Research Cen
Autor:
Noah, James
Publikováno v:
International Journal of High Throughput Screening.
James W NoahDrug Discovery Division, Southern Research Institute, Birmingham, Alabama, USAAbstract: High-throughput screening (HTS) campaigns have become a starting point for many drug discovery programs and are being conducted not only by large phar